Cargando…
The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis
BACKGROUND: Kawasaki disease (KD) is a self-limited illness that results in coronary artery aneurysms (CAAs) and threatens children’s health and lives. The therapeutic effects of single intravenous immunoglobulin gamma (IVIG) vs. infliximab (IFX) (with or without IVIG) in young children with KD rema...
Autores principales: | Li, Dan, Li, Xiaohui, Dou, Wenting, Zheng, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193009/ https://www.ncbi.nlm.nih.gov/pubmed/34189087 http://dx.doi.org/10.21037/tp-20-482 |
Ejemplares similares
-
Efficacy of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis
por: Lu, Zhongxing, et al.
Publicado: (2021) -
Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010) -
Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014) -
Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis
por: Zheng, Zhimin, et al.
Publicado: (2021) -
Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)